CPT code 93287 denotes a face‑to‑face evaluation conducted before or after a surgical procedure to optimally adjust the parameters of an implanted single, dual, or multiple‑lead implantable cardioverter‑defibrillator (ICD). The code bundles both professional and technical components of device interrogation and reprogramming, making it central to managing patients with implanted defibrillators. Nationally, accurate use of this code affects clinical documentation, device management programs, and reimbursement for cardiac electrophysiology services.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise review of the clinical context for ICD reprogramming, common billing considerations, relevant modifiers provided in the input, and operational benchmarks where available. The publication outlines expected sites of service and the service type associated with the code, clarifies what the code represents clinically, and identifies areas where input data is not available. The goal is to give clinicians, coders, and administrators a clear national‑level summary of CPT code 93287 so they can align documentation and billing processes with clinical practice and payer expectations.